Ospedale San Carlo di Nancy
Ospedale San Carlo di Nancy
Italy, Rome
Alessandro Calarco
19 years of experience
Clinic is certified :
Why do patients choose Italy for laparoscopic prostatectomy?
Access advanced Laparoscopic prostatectomy solutions in trusted clinics .
| Italy | Turkey | Austria | |
| Laparoscopic prostatectomy | - | from $7,500 | from $18,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Laparoscopic prostatectomy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Laparoscopic prostatectomy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Laparoscopic prostatectomy journey.
Day 1 - Arrival
Day 2 - Pre-Operation
Day 3 - Laparoscopic Prostatectomy
Day 4-7 - Post-Operation
Week 1-2 - Rehabilitation
Week 3-4
Week 5-6
Please note that each patient"s recovery time can vary based on individual health conditions and the complexity of the surgery.
Professor Luca Carmignani has performed over 10,000 surgeries, specializing in robotic laparoscopy and prostate treatments at Policlinico San Donato Research Hospital.
Dr. Alessandro Calarco is a skilled urologist with expertise in minimally invasive and endourological procedures. He performs percutaneous lithotripsy, ureterorenoscopy, tumor ablation, and advanced reconstructive surgeries. Dr. Calarco has received international recognition for his clinical work and research. He completed advanced training in Sweden and the UK.
Dr. Calarco graduated with top honors from Università Cattolica del Sacro Cuore in Rome. He completed his Urology specialization and earned a PhD in Oncological Urology at the same university. His research focuses on prostate cancer biomarkers and exosomes. He has also helped develop clinical protocols for hormone-refractory prostate cancer.
He serves as National Head of Urology for SPIGC and is a member of the European Board of Urology. Dr. Calarco holds an international patent for a device that improves percutaneous nephrolithotripsy. He has published extensively and received several awards for surgical innovation and education.
It is a minimally invasive procedure for removing the prostate gland, often used in prostate cancer treatment.